news copy paste: #vrus #frewil Statement of

New Post Public Reply Private Reply Replies (0) Message Board
Frewil
382
news
copy paste:


#vrus

#frewil


Statement of Ownership (sc 13g)

Source: Edgar (US Regulatory)

 

 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ___)*
  VERUS INTERNATIONAL, INC.
 (Name of Issuer)
 
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
 
92537A106
(CUSIP Number)
 
April 10, 2019
 (Date of Event Which Requires Filing this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
☐Rule 13d-1(b)☒Rule 13d-1(c)☐Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “ filed ” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act ”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 

 

 

CUSIP No. 92537A10613GPage 2 of 7
 
 
 1  
Name of Reporting Persons
 
Monaker Group, Inc.
 2 
Check the Appropriate Box if a Member of a Group
(see instructions)
(a) ☐
(b) ☐
 
 3 
SEC Use Only
 
 4 
Citizenship or Place of Organization
 
Nevada
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person with:
 5  
Sole Voting Power
 
-0-
 6 
Shared Voting Power
 
165,372,234*
 7 
Sole Dispositive Power
 
-0-
 8 
Shared Dispositive Power
 
165,372,234*
 9 
Aggregate Amount Beneficially Owned by Each Reporting Person
 
165,372,234*
10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)  [ ]11 
Percent of Class Represented by Amount in Row 9
 
9.9%*
12 
Type of Reporting Person (see instructions)
 
CO
       
 
 
* See discussion below, including the Ownership Blocker. 

 

 

CUSIP No. 92537A10613GPage 3 of 7
 
 
 1  
Name of Reporting Persons
 
William Kerby
 2 
Check the Appropriate Box if a Member of a Group
(see instructions)
(a) ☐
(b) ☐
 
 3 
SEC Use Only
 
 4 
Citizenship or Place of Organization
 
United States
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person with:
 5  
Sole Voting Power
 
-0-
 6 
Shared Voting Power
 
165,372,234*
 7 
Sole Dispositive Power
 
-0-
 8 
Shared Dispositive Power
 
165,372,234*
 9 
Aggregate Amount Beneficially Owned by Each Reporting Person
 
165,372,234*
10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions)  [ ]11 
Percent of Class Represented by Amount in Row 9
 
9.9%*
12 
Type of Reporting Person (see instructions)
 
IN
       
 
 
* See discussion below, including the Ownership Blocker. 

 

 

CUSIP No. 92537A10613GPage 4 of 7
 
 
SCHEDULE 13G
This Schedule 13G (this “ Schedule 13G ”) is being filed on behalf of Monaker Group, Inc., a Nevada corporation (“ Monaker ”), and the Chief Executive Officer of Monaker, Mr. William Kerby, relating to the common stock, $0.001 par value per share (“ Common Stock ”) of Verus International, Inc., a Delaware corporation (the “ Issuer ”).
This Schedule 13G relates to shares of Common Stock of the Issuer received by, and receivable by, Monaker pursuant to the terms of an Inducement Agreement dated April 10, 2019, and effective February 8, 2019, entered into between Monaker and the Issuer (the “ Inducement Agreement ”). Pursuant to the Inducement Agreement, Monaker agreed to amend the designation of the Series A Convertible Preferred Stock of the Issuer (the “ Series A Preferred Stock ”)(of which Monaker held, and continues to hold 44,470,101 shares of such Series A Preferred Stock, which converts into common stock of the Issuer, and votes on all stockholder matters, on a one-for-one basis, subject to the Ownership Blocker (discussed below)), to remove certain anti-dilution rights described therein; and the Issuer agreed to issue Monaker 152,029,899 shares of common stock pursuant to the anti-dilution rights of that certain Settlement Agreement by and among the Issuer, Monaker, American Stock Transfer & Trust Company, LLC and NestBuilder.com Corp. executed on or about December 22, 2017.
The designation of the Series A Preferred Stock, as amended, includes a 9.99% beneficial ownership limitation, preventing Monaker from converting such Series A Preferred Stock into common stock of the Issuer (and reducing the voting rights of such preferred stock proportionally), if upon such conversion, Monaker, its affiliates and/or any group which it is a part of, would own greater than 9.99% of the Issuer’s common stock (the “ Ownership Blocker ”).
The 165,372,234 shares of Common Stock reported as beneficially owned by Monaker above include the 152,029,899 shares of common stock which it is due to receive pursuant to the terms of the Inducement Agreement and the portion (13,342,335 shares) of the 44,470,101 shares of common stock issuable to Monaker upon conversion of the Series A Preferred Stock, without exceeding the Ownership Blocker.
As Chief Executive Officer of Monaker, Mr. Kerby may direct the vote and disposition of the shares of common stock beneficially owned by Monaker.
 
Item 1(a)Name of Issuer.   Verus International, Inc.
 
Item 1(b)Address of Issuer’s Principal Executive Offices.  
9841 Washingtonian Blvd #390
Gaithersburg, Maryland 20878
 
Item 2(a)Name of Person Filing.   Monaker Group, Inc., a Nevada corporation and Mr. William Kerby.  Item 2(b)Address of Principal Business Office, or, if none, Residence.   
2893 Executive Park Drive, Suite 201
Weston, Florida 33331
 
Item 2(c)Citizenship or Place of Organization.   Monaker is a Nevada corporation. Mr. William Kerby is the Chief Executive Officer of Monaker and is a U.S. citizen.
 

 

 

CUSIP No. 92537A10613GPage 5 of 7
 
 
Item 2(d)Title of Class of Securities.   Common stock, $0.001 par value per share (the “ Common Stock ”).
 
Item 2(e)CUSIP Number.   92537A106
 
Item 3Reporting Person.
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:
 
(a)   ☐   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)   ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)   ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)   ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
(e)   ☐ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)   ☐ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)   ☐ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)   ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)   ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)   ☐ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
(k)   ☐ Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____
 
Item 4Ownership.
 
 (a)Monaker is the beneficial owner of 165,372,234 shares of Common Stock. By virtue of his relationship with Monaker, discussed in further detail above, Mr. Kerby may be deemed to beneficially own the shares of Common Stock beneficially owned by Monaker.
 
 (b)Monaker is the beneficial owner of 9.9% of the outstanding shares of Common Stock. This percentage is determined by dividing 165,372,234, by 1,665,372,234, which equals (i) the number of shares of Common Stock issued and outstanding as of March 25, 2019 (1,500,000,000) as reported by the Issuer in the Quarterly Report on Form 10-Q for the quarter ended January 31, 2019, filed by the Issuer with the Securities and Exchange Commission on March 25, 2019, plus (ii) the 152,029,899 shares of Common Stock due pursuant to terms of the Inducement Agreement, and (iii) the 13,342,335 shares of common stock issuable to Monaker upon conversion of the Series A Preferred Stock, without exceeding the Ownership Blocker (notwithstanding the fact that the Issuer’s aggregate authorized shares of Common Stock currently totals 1,500,000,000 and as such the Issuer will need to increase its authorized Common Stock and/or reduce its outstanding Common Stock, in the future to allow the issuance of the shares of Common Stock which Monaker beneficially owns). By virtue of his relationship with Monaker, discussed in further detail above, Mr. Kerby may be deemed to beneficially own the shares of Common Stock beneficially owned by Monaker.
 

 

 

CUSIP No. 92537A10613GPage 6 of 7
 
 
 (c)Mr. Kerby may be deemed to have shared power with Monaker, to vote and dispose of the 165,372,234 shares of Common Stock beneficially owned by Monaker.
 
Item 5Ownership of Five Percent or Less of a Class.   Inapplicable.
 
Item 6Ownership of More Than Five Percent on Behalf of Another Person.   Inapplicable.
 
Item 7Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.   Inapplicable.
 
Item 8Identification and Classification of Members of the Group.   Inapplicable.
 
Item 9Notice of Dissolution of Group.   Inapplicable.
 
Item 10Certification.   By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
 
Exhibits Exhibit 99.1   Joint Filing Agreement dated April 11, 2019, between Monaker Group, Inc. and Mr. William Kerby.
 

 

 

CUSIP No. 92537A10613GPage 7 of 7
 
 
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: April 11, 2019
 
 Monaker Group, Inc. 
/s/ William Kerby
William Kerby
Chief Executive Officer 
/s/ William Kerby
William Kerby
 
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
 
 

 

 

Verus International, Inc. (VRUS) Stock Research Links

VRUS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 2

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 3

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 1

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 2

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 7

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 6

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 6

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 5

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading

Top 5 Most Recently Viewed Articles

Experience the Thrill of the 33rd UAE President Cup Event

Updated Category News Views 186

The Anticipation of the 33rd UAE President Cup Abu Dhabi Turf Club is gearing up for the highly anticipated 33rd edition of the President of the UAE Cup for Arabian Purebred Horses. Scheduled during the vibrant 2025–2026 season, this event shines a light on the rich culture and love for Arabian horses. The race will take place under the esteemed patronage of His...

Continue Reading
Dover Expands Product Line with Dryer Technology Acquisition

Updated Category News Views 147

Dover Expands Product Line with Dryer Technology Acquisition Dover, a notable player in the global manufacturing sector, recently announced a strategic acquisition centered on enhancing its technological capabilities. The company, which trades on the New York Stock Exchange under the ticker symbol DOV, has taken a significant step by acquiring specific assets from Carter...

Continue Reading
Gentex Corporation Secures Air Force Contract for Night Spectacles

Updated Category News Views 135

Gentex Corporation Awarded USAF Contract Gentex Corporation, a prominent name in personal protection and situational awareness solutions, has made significant strides with its latest achievement. The company recently received a contract to develop and produce the Aircrew Laser Eye Protection (ALEP) Night Spectacle for the United States Air Force. This contract marks an...

Continue Reading
Hyster-Yale Increases Dividend to Shareholders in Announcement

Updated Category News Views 145

Hyster-Yale Declares Increased Quarterly Dividend Hyster-Yale, Inc. (NYSE: HY) recently revealed that its Board of Directors has approved a rise in the regular cash dividend from 35 cents to 36 cents per share. This increase reflects the company’s commitment to providing value to its shareholders. Details of the Dividend Payment The increased dividend will be applicable...

Continue Reading
MediWound Enhances Production Capacity with New Facility

Updated Category News Views 141

MediWound Expands Manufacturing Capacity for NexoBrid MediWound Ltd., a pioneering company in the field of enzymatic therapeutics, has successfully completed the important commissioning process for its extended GMP manufacturing facility. This advancement marks a significant moment for the organization, setting the stage for achieving a remarkable sixfold increase in...

Continue Reading